Alzheimer's disease (AD) and sporadic Creutzfeldt-Jakob disease (sCJD) are both characterized by extracellular pathologically conformed aggregates of amyloid proteins-amyloid β-protein (Aβ) and prion protein (PrPSc), respectively. To investigate the potential morphological colocalization of Aβ and PrPSc aggregates, we examined the hippocampal regions (archicortex and neocortex) of 20 subjects with confirmed comorbid AD and sCJD using neurohistopathological analyses, immunohistochemical methods, and confocal fluorescent microscopy. Our data showed that extracellular Aβ and PrPSc aggregates tended to be, in most cases, located separately, and "compound" plaques were relatively rare. We observed PrPSc plaque-like structures in the periphery of the non-compact parts of Aβ plaques, as well as in tau protein-positive dystrophic structures. The AD ABC score according to the NIA-Alzheimer's association guidelines, and prion protein subtype with codon 129 methionine-valine (M/V) polymorphisms in sCJD, while representing key characteristics of these diseases, did not correlate with the morphology of the Aβ/PrPSc co-aggregates. However, our data showed that PrPSc aggregation could dominate during co-aggregation with non-compact Aβ in the periphery of Aβ plaques.

Department of Pathology 1st Faculty of Medicine Charles University and General University Hospital 4 Krc 14059 Prague Czech Republic

Department of Pathology 3rd Faculty of Medicine Charles University and University Hospital Kralovske Vinohrady 4 Krc 14059 Prague Czech Republic

Department of Pathology and Molecular Medicine 3rd Faculty of Medicine Charles University and Thomayer University Hospital Videnska 800 4 Krc 14059 Prague Czech Republic

See more in PubMed

Huang W.-J., Chen W.-W., Zhang X. Prions mediated neurodegenerative disorders. Eur. Rev. Med. Pharmacol. Sci. 2015;19:4028–4034. PubMed

Thal D.R., Walter J., Saido T.C., Fändrich M. Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer’s disease. Acta Neuropathol. 2015;129:167–182. doi: 10.1007/s00401-014-1375-y. PubMed DOI

Obeng R. Amyloid Beta and Amyloid Beta Precursor Protein. [(accessed on 12 November 2020)]; Available online: https://www.pathologyoutlines.com/topic/stainsamyloidbetaapp.html.

Litak J., Mazurek M., Kulesza B., Szmygin P., Litak J., Kamieniak P., Grochowski C. Cerebral Small Vessel Disease. Int. J. Mol. Sci. 2020;21:9729. doi: 10.3390/ijms21249729. PubMed DOI PMC

Ben Halima S., Mishra S., Raja K.M.P., Willem M., Baici A., Simons K., Brüstle O., Koch P., Haass C., Caflisch A., et al. Specific Inhibition of β-Secretase Processing of the Alzheimer Disease Amyloid Precursor Protein. Cell Rep. 2016;14:2127–2141. doi: 10.1016/j.celrep.2016.01.076. PubMed DOI

Singh J., Udgaonkar J.B. Molecular Mechanism of the Misfolding and Oligomerization of the Prion Protein: Current Understanding and Its Implications. Biochemistry. 2015;54:4431–4442. doi: 10.1021/acs.biochem.5b00605. PubMed DOI

Van Der Kant R., Goldstein L.S. Cellular Functions of the Amyloid Precursor Protein from Development to Dementia. Dev. Cell. 2015;32:502–515. doi: 10.1016/j.devcel.2015.01.022. PubMed DOI

Gamez P., Caballero A.B. Copper in Alzheimer’s disease: Implications in amyloid aggregation and neurotoxicity. AIP Adv. 2015;5:092503. doi: 10.1063/1.4921314. DOI

Atwood C.S., Scarpa R.C., Huang X., Moir R.D., Jones W.D., Fairlie D.P., Tanzi R.E., Bush A.I. Characterization of Copper Interactions with Alzheimer Amyloid β Peptides. J. Neurochem. 2008;75:1219–1233. doi: 10.1046/j.1471-4159.2000.0751219.x. PubMed DOI

Watts J.C., Bourkas M.E.C., Arshad H. The function of the cellular prion protein in health and disease. Acta Neuropathol. 2017;135:159–178. doi: 10.1007/s00401-017-1790-y. PubMed DOI

Gunther E.C., Strittmatter S.M. β-amyloid oligomers and cellular prion protein in Alzheimer’s disease. J. Mol. Med. 2010;88:331–338. doi: 10.1007/s00109-009-0568-7. PubMed DOI PMC

Parkin E.T., Watt N.T., Hussain I., Eckman E.A., Eckman C.B., Manson J.C., Baybutt H.N., Turner A.J., Hooper N.M. Cellular prion protein regulates beta-secretase cleavage of the Alzheimer’s amyloid precursor protein. Proc. Natl. Acad. Sci. USA. 2007;104:11062–11067. doi: 10.1073/pnas.0609621104. PubMed DOI PMC

Ezpeleta J., Baudouin V., Arellano-Anaya Z.E., Boudet-Devaud F., Pietri M., Baudry A., Haeberlé A.-M., Bailly Y., Kellermann O., Launay J.-M., et al. Production of seedable Amyloid-β peptides in model of prion diseases upon PrPSc-induced PDK1 overactivation. Nat. Commun. 2019;10:1–13. doi: 10.1038/s41467-019-11333-3. PubMed DOI PMC

Plant L.D., Boyle J.P., Smith I.F., Peers C., Pearson H.A. The Production of Amyloid β Peptide Is a Critical Requirement for the Viability of Central Neurons. J. Neurosci. 2003;23:5531–5535. doi: 10.1523/JNEUROSCI.23-13-05531.2003. PubMed DOI PMC

Vincent B., Sunyach C., Orzechowski H.-D., George-Hyslop P.S., Checler F. p53-Dependent Transcriptional Control of Cellular Prion by Presenilins. J. Neurosci. 2009;29:6752–6760. doi: 10.1523/JNEUROSCI.0789-09.2009. PubMed DOI PMC

Zhang Y., Zhao Y., Zhang L., Yu W., Wang Y., Chang W. Cellular Prion Protein as a Receptor of Toxic Amyloid-β42 Oligomers Is Important for Alzheimer’s Disease. Front. Cell. Neurosci. 2019;13:339. doi: 10.3389/fncel.2019.00339. PubMed DOI PMC

Liberski P.P. Axonal changes in experimental prion diseases recapitulate those following constriction of postganglionic branches of the superior cervical ganglion: A comparison 40 years later. Prion. 2019;13:83–93. doi: 10.1080/19336896.2019.1595315. PubMed DOI PMC

Gomes L.A., Hipp S.A., Upadhaya A.R., Balakrishnan K., Ospitalieri S., Koper M.J., Largo-Barrientos P., Uytterhoeven V., Reichwald J., Rabe S., et al. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein. Acta Neuropathol. 2019;138:913–941. doi: 10.1007/s00401-019-02053-5. PubMed DOI

Ondrejcak T., Klyubin I., Corbett G.T., Fraser G., Hong W., Mably A.J., Gardener M., Hammersley J., Perkinton M.S., Billinton A., et al. Cellular Prion Protein Mediates the Disruption of Hippocampal Synaptic Plasticity by Soluble Tau In Vivo. J. Neurosci. 2018;38:10595–10606. doi: 10.1523/JNEUROSCI.1700-18.2018. PubMed DOI PMC

Jankovska N., Olejar T., Matej R. Extracellular Amyloid Deposits in Alzheimer’s and Creutzfeldt–Jakob Disease: Similar Behavior of Different Proteins? Int. J. Mol. Sci. 2020;22:7. doi: 10.3390/ijms22010007. PubMed DOI PMC

Jankovska N., Olejar T., Kukal J., Matej R. Different Morphology of Neuritic Plaques in the Archicortex of Alzheimer’s Disease with Comorbid Synucleinopathy: A Pilot Study. Curr. Alzheimer Res. 2021;17:948–958. doi: 10.2174/1875692117999201215162043. PubMed DOI

Rossi M., Kai H., Baiardi S., Bartoletti-Stella A., Carlà B., Zenesini C., Capellari S., Kitamoto T., Parchi P. The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins. Acta Neuropathol. Commun. 2019;7:53. doi: 10.1186/s40478-019-0706-6. PubMed DOI PMC

Furukawa F., Sanjo N., Kobayashi A., Hamaguchi T., Yamada M., Kitamoto T., Mizusawa H., Yokota T. Specific amyloid-β42 deposition in the brain of a Gerstmann-Sträussler-Scheinker disease patient with a P105L mutation on the prion protein gene. Prion. 2018;12:315–319. doi: 10.1080/19336896.2018.1541689. PubMed DOI PMC

Miyazono M., Kitamoto T., Iwaki T., Tateishi J. Colocalization of prion protein and beta protein in the same amyloid plaques in patients with Gerstmann-Sträussler Syndrome. Acta Neuropathol. 1992;83:333–339. doi: 10.1007/BF00713522. PubMed DOI

Hainfellner J.A., Wanschitz J., Jellinger K., Liberski P.P., Gullotta F., Budka H. Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease. Acta Neuropathol. 1998;96:116–122. doi: 10.1007/s004010050870. PubMed DOI

Ferrer I., Blanco R., Carmona M., Puig B., Ribera R., Rey M.J., Ribalta T. Prion protein expression in senile plaques in Alzheimer’s disease. Acta Neuropathol. 2001;101:49–56. doi: 10.1007/s004010000271. PubMed DOI

Duyckaerts C., Dickson D.W. Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders. 2nd ed. Wiley-Blackwell; Hoboken, NJ, USA: 2011. pp. 62–68.

Han J., Zhang J., Yao H., Wang X., Li F., Chen L., Gao C., Gao J., Nie K., Zhou W., et al. Study on interaction between microtubule associated protein tau and prion protein. Sci. China Ser. C Life Sci. 2006;49:473–479. doi: 10.1007/s11427-006-2019-9. PubMed DOI

Dlouhy S.R., Hsiao K., Farlow M.R., Foroud T., Conneally P.M., Johnson P., Prusiner S.B., Hodes M.E., Ghetti B. Linkage of the Indiana kindred of Gerstmann-Sträussler-Scheinker disease to the prion protein gene. Nat. Genet. 1992;1:64–67. doi: 10.1038/ng0492-64. PubMed DOI

Ishizawa K., Mitsufuji T., Shioda K., Kobayashi A., Komori T., Nakazato Y., Kitamoto T., Araki N., Yamamoto T., Sasaki A. An autopsy report of three kindred in a Gerstmann-Sträussler-Scheinker disease P105L family with a special reference to prion protein, tau, and beta-amyloid. Brain Behav. 2018;8:e01117. doi: 10.1002/brb3.1117. PubMed DOI PMC

Race B., Phillips K., Kraus A., Chesebro B. Phosphorylated human tau associates with mouse prion protein amyloid in scrapie-infected mice but does not increase progression of clinical disease. Prion. 2016;10:319–330. doi: 10.1080/19336896.2016.1199313. PubMed DOI PMC

Montine T.J., Phelps C.H., Beach T.G., Bigio E.H., Cairns N.J., Dickson D.W., Duyckaerts C., Frosch M.P., Masliah E., Mirra S.S., et al. National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: A practical approach. Acta Neuropathol. 2011;123:1–11. doi: 10.1007/s00401-011-0910-3. PubMed DOI PMC

Hyman B.T., Phelps C.H., Beach T.G., Bigio E.H., Cairns N.J., Carrillo M.C., Dickson D.W., Duyckaerts C., Frosch M.P., Masliah E., et al. National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease. Alzheimer Dement. 2012;8:1–13. doi: 10.1016/j.jalz.2011.10.007. PubMed DOI PMC

Parchi P., De Boni L., Saverioni D., Cohen M.L., Ferrer I., Gambetti P., Gelpi E., Giaccone G., Hauw J.-J., Höftberger R., et al. Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: An inter-rater study among surveillance centres in Europe and USA. Acta Neuropathol. 2012;124:517–529. doi: 10.1007/s00401-012-1002-8. PubMed DOI PMC

Autopsy. Netherlands Brain Bank. [(accessed on 14 February 2021)]; Available online: https://www.brainbank.nl/brain-tissue/autopsy/

Biomarkers Analysis and Clinical Manifestations in Comorbid Creutzfeldt-Jakob Disease: A Retrospective Study in 215 Autopsy Cases

Extracellular Prion Protein Aggregates in Nine Gerstmann-Sträussler-Scheinker Syndrome Subjects with Mutation P102L: A Micromorphological Study and Comparison with Literature Data